Aprovisionamento de fábrica de GMP Lanzoprazol Enteric-Coated Tablets
| Referência Preço FOB: | US$ 0,1-1,00 / tablet |
|---|---|
| Quantidade Mínima: | 30.000 tablet |
| Quantidade Mínima | Referência Preço FOB |
|---|---|
| 30.000 tablet | US$ 0,1-1,00 |
| Porto: | Shanghai, China |
|---|---|
| Capacidade de Produção: | 0.5 Billion Tablets/Year |
| Condições de Pagamento: | L/C, T/T, D/P, Western Union, Paypal |
Itens Similares
Carregando...
Você pode gostar
Carregando...
Descrição de Produto
Informações da Empresa
Endereço:
Luoxin Industrial Park, No. 18, Huxi Road, Luozhuang District, Linyi City, Shandong Province
Tipo de Negócio:
Empresa Comercial
Escala de Negócios:
Metalúrgica, Mineral Energia, Químicas, Saúde & Medicina
Certificação de Sistema de Gestão:
ISO 9001, ISO 14001, GMP
Produtos Principais:
Pharmaceutical
introdução da companhia:
Chengdu Medi-sourcing International Trade Co., Ltd. is one of the subsidiaries of Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (Luoxin Pharmaceutical Group), responsible for the export business of all products from Luoxin Group and others agent products.
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a healthcare conglomerate that is engaged in pharmaceutical research and development, manufacture, sales, and healthcare service. Established from 1988, Luoxin Pharmaceutical Group has six manufacture sites covering formulations, APIs and Intermediates, Chinese medicine and its extracts and Medical apparatus and instruments products. Benefiting from the layout structure of the whole industry chain, Luoxin Pharmaceutical has a strong development momentum and successfully listed on the A-share market in 2019.
Luoxin Pharmaceutical Group has more than 50 production lines and holds on 300 marketing licenses. The formulation products from three formulation factories of Luoxin Pharmaceutical Group cover tablets, capsules, granules, dry suspension, pellets, sterile powder for Injection, lyophilized powder for injection, small-volume parenterals, large-volume parenterals, aerosols, sprays and prefilled.
Following the "Belt and Road initiative" national strategy, Luoxin Pharmaceutical Group steps forwards internationalization and develops rapidly with overseas Food and Drug Administration approvals certificates or licenses. Our products have been shipped to East Asia, South Asia, Southeast Asia, Africa, South America, Europe and other regional markets.
Warmly welcome to contact us and look forward to building a long-term business relationship with you in recent future!
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a healthcare conglomerate that is engaged in pharmaceutical research and development, manufacture, sales, and healthcare service. Established from 1988, Luoxin Pharmaceutical Group has six manufacture sites covering formulations, APIs and Intermediates, Chinese medicine and its extracts and Medical apparatus and instruments products. Benefiting from the layout structure of the whole industry chain, Luoxin Pharmaceutical has a strong development momentum and successfully listed on the A-share market in 2019.
Luoxin Pharmaceutical Group has more than 50 production lines and holds on 300 marketing licenses. The formulation products from three formulation factories of Luoxin Pharmaceutical Group cover tablets, capsules, granules, dry suspension, pellets, sterile powder for Injection, lyophilized powder for injection, small-volume parenterals, large-volume parenterals, aerosols, sprays and prefilled.
Following the "Belt and Road initiative" national strategy, Luoxin Pharmaceutical Group steps forwards internationalization and develops rapidly with overseas Food and Drug Administration approvals certificates or licenses. Our products have been shipped to East Asia, South Asia, Southeast Asia, Africa, South America, Europe and other regional markets.
Warmly welcome to contact us and look forward to building a long-term business relationship with you in recent future!
